Galen 2002sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-08-04
Share capital
6 400 000,00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-84609-35288-DGRGJ-20

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 12.18mMedianUSD 1.75mAverageUSD 5.00m
Net profit
This companyUSD 379.44kMedianUSD 17.49kAverageUSD 85.24k
Operating costs
This companyUSD 11.67mMedianUSD 1.72mAverageUSD 4.85m
Assets
This companyUSD 4.31mMedianUSD 495.38kAverageUSD 1.71m

Bank accounts

Registered as a VAT taxpayer on 2004-07-28. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Galen 2002 has been an NFZ healthcare provider since 2019. In 2026 it is performing 5 contracts with a total value of USD 607.78. All its contracts were worth USD 4.11k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Programy pilotażowewarmińsko-mazurskie1USD 324.15
Programy pilotażowewielkopolskie1USD 283.63
Inne usługi realizowane w aptekachopolskie1USD 0.00
Inne usługi realizowane w aptekachwielkopolskie2USD 0.00

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Aleksandra Olszacka – Vice President of the Management Board
Bożena Szymańska – President of the Management Board
Katarzyna Nockowska Stańczak – Vice President of the Management Board

Manner of representation

If a multi-member management board is appointed, two members of the management board acting jointly or one member of the management board acting together with a commercial proxy are authorized to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
3,072$414,910.8624%
9,728$1,313,884.3976%

Beneficial owners

Person

Competitors

Name
Management CompanyS.A.
Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o.
APIS Farmacjasp. z o.o.
Farmjugsp. z o.o.
MybestpharmS.A.
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Pikadasp. z o.o.
Awicennasp. j.

Change history

DateEvent
2025-02-05Address change
2015-07-07PKD change
2010-03-04PKD change
2008-03-06Share capital change
2007-09-27Share capital change

FAQ

Last updated: 2026-05-17